Twitter | Pretraživanje | |
Pretraživanje Osvježi
RheumaHighlights 1 h
Good news! The ACR/ARP highlights are now available in Chinese 🇨🇳 and Japanese 🇯🇵 languages ➡️ Get the most out of !
Reply Retweet Označi sa "sviđa mi se"
Martin Greco 16. stu
Presenting our poster "Antisynthetase Syndromes: Correlation of IIFA Patterns with Diagnosis Criteria Fulfillment" at in Atlanta. Many thanks to , and for contributing to this project and its presentation at this meeting.
Reply Retweet Označi sa "sviđa mi se"
𝐽𝑎𝑣𝑖𝑒𝑟 𝑀𝑒𝑟𝑎𝑦𝑜-𝐶ℎ𝑎𝑙𝑖𝑐𝑜 13. stu
new Guidelines OA: 🥊exercise (aerobic/streng/neuroM/aquatic🏖) 🥝🥬🔽weigth🚫🍔🚫 ✅tai chi 🚫TENS🚫(no evidence) ✅topical/oral NDSAIDs/intraarticular GCs 🚫intraarticular HyA (hip)🚫 🚫glucosamine and/or chondroitin🚫 (Look slides 👁👁)
Reply Retweet Označi sa "sviđa mi se"
Mike Putman 21. stu
"Update in Myositis" session with tips on how to use the new classification criteria I honestly find them difficult and only reference in marginal cases Excellent tables from the presentation, though - great reference for antibodies and presentations!
Reply Retweet Označi sa "sviđa mi se"
Mike Putman 22. stu
- Update in Myositis: Don't forget about toxin induced myopathy! Important mimickers related to treatment we give! 1. Steroid: myopathy w/o inflammation 2. Colchicine: vacuolar myopathy 3. Anti-malarial: vacuolar degeneration P.S. This might be good boards prep...
Reply Retweet Označi sa "sviđa mi se"
Lauren Gelman 25. stu
Excited to share this report of the big takeaways for patients, with lots of help from & others. Too much to pack into just one resource, so we have 6 wrap-up stories this year!
Reply Retweet Označi sa "sviđa mi se"
American College of Rheumatology 4. velj
We’ve got another special Hot Topics episode available on the podcast! Join our host Dr. Hausmann, along with Dr. Ali Duarte Garcia and Dr. Suleman Bhana, as they discuss studies featured in press conferences.
Reply Retweet Označi sa "sviđa mi se"
Sjögren’s Expertise Center Groningen 12. stu
Multiple SS-clinical trial results presented at . The challenge to identify responders remains! Lots of interest for our abatacept follow-up data (week 48) presented by Jolien!
Reply Retweet Označi sa "sviđa mi se"
Dr. John Cush 16. pro
Retrospective cohort study of 154 RA patients undergoing 244 major surgeries in shows that perioperative use of DMARDs (39%) or biologics (13%) was not associated with 30-day odds of post-operative infection Abst #1805
Reply Retweet Označi sa "sviđa mi se"
Mai Abdelnabi, MD 13. stu
Scleroderma treatment options
Reply Retweet Označi sa "sviđa mi se"
Kanika Monga, MD 15. stu
❓Can the happiest subspecialists experience burnout? 🌻 Now back from , I am rekindled with a new spark and inspiration thanks to each and every one of you! ⬇️ Please read my article for on burnout in rheumatology:
Reply Retweet Označi sa "sviđa mi se"
Laurent ARNAUD 14. stu
🔹Are you looking 🔎 for a visual summary 📑 of the main (and their 🎯 & ) for the 💊 of systemic presented at ? 🔹 Well...here it is!
Reply Retweet Označi sa "sviđa mi se"
Mike Putman 3. pro
Management of GCA Guidelines from (FIXED!): The presenter went quickly by the slide on methotrexate & the slide deck was not available during the presentation. Small update now that slides are available, MTX recs included: "[MTX] can be considered as initial treatment"
Reply Retweet Označi sa "sviđa mi se"
Dr. Rachel Tate 14. stu
Asymptomatic sacroiliitis was observed in about 15% of young IBD pts. Entero MRI may be helpful for early inflammatory changes in IBD pts. abst #1174
Reply Retweet Označi sa "sviđa mi se"
Dr. Paul Sufka 23. stu
I missed this one during (found via 's weekly roundup): Abstract L19: Early study, but BAFF inhibitor Ianalumab met its primary endpoint in primary Sjogren's.
Reply Retweet Označi sa "sviđa mi se"
emily creek 13. stu
Thanks to the AF patients who shared their voice and influenced the new ACR/AF OA Treatment Guidelines.
Reply Retweet Označi sa "sviđa mi se"
Eileen Davidson 18. stu
I wrote about being a first time patient at . What an amazing experience, I WILL go again! Thank you for sponsoring me! Thank you for being my mentor. Also thanks to those who came to see me speak!
Reply Retweet Označi sa "sviđa mi se"
David Liew 15. stu
Rheumatic irAEs can: - be severe - be related to oncological response - come on anytime after immunotherapy initiation - persist long after immunotherapy cessation Data from :
Reply Retweet Označi sa "sviđa mi se"
Madelaine Feldman 13. stu
My Utilization management presentation at was picked up by . Check it out. How Prior Authorization, Step Therapy Result in Medication Discontinuation and Worse Outcomes via
Reply Retweet Označi sa "sviđa mi se"
emily creek 13. stu
ACR/AF OA Treatment Guidelines include strong recommendation for exercise. .
Reply Retweet Označi sa "sviđa mi se"